These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
535 related articles for article (PubMed ID: 27112894)
1. A comparative study on the efficiency of chitosan-N-acetylcysteine, chitosan oligosaccharides or carboxymethyl chitosan surface modified nanostructured lipid carrier for ophthalmic delivery of curcumin. Li J; Liu D; Tan G; Zhao Z; Yang X; Pan W Carbohydr Polym; 2016 Aug; 146():435-44. PubMed ID: 27112894 [TBL] [Abstract][Full Text] [Related]
2. Transport mechanism of chitosan-N-acetylcysteine, chitosan oligosaccharides or carboxymethyl chitosan decorated coumarin-6 loaded nanostructured lipid carriers across the rabbit ocular. Li J; Tan G; Cheng B; Liu D; Pan W Eur J Pharm Biopharm; 2017 Nov; 120():89-97. PubMed ID: 28867370 [TBL] [Abstract][Full Text] [Related]
3. Potential advantages of a novel chitosan-N-acetylcysteine surface modified nanostructured lipid carrier on the performance of ophthalmic delivery of curcumin. Liu D; Li J; Pan H; He F; Liu Z; Wu Q; Bai C; Yu S; Yang X Sci Rep; 2016 Jun; 6():28796. PubMed ID: 27350323 [TBL] [Abstract][Full Text] [Related]
4. Ex Vivo and in Vivo Evaluation of the Effect of Coating a Coumarin-6-Labeled Nanostructured Lipid Carrier with Chitosan-N-acetylcysteine on Rabbit Ocular Distribution. Liu D; Li J; Cheng B; Wu Q; Pan H Mol Pharm; 2017 Aug; 14(8):2639-2648. PubMed ID: 28664726 [TBL] [Abstract][Full Text] [Related]
5. Nanostructured lipid carrier (NLC) coated with Chitosan Oligosaccharides and its potential use in ocular drug delivery system. Luo Q; Zhao J; Zhang X; Pan W Int J Pharm; 2011 Jan; 403(1-2):185-91. PubMed ID: 20951778 [TBL] [Abstract][Full Text] [Related]
6. Novel surface-modified nanostructured lipid carriers with partially deacetylated water-soluble chitosan for efficient ocular delivery. Tian B; Luo Q; Song S; Liu D; Pan H; Zhang W; He L; Ma S; Yang X; Pan W J Pharm Sci; 2012 Mar; 101(3):1040-9. PubMed ID: 22102480 [TBL] [Abstract][Full Text] [Related]
7. N-acetyl-L-cysteine functionalized nanostructured lipid carrier for improving oral bioavailability of curcumin: preparation, in vitro and in vivo evaluations. Tian C; Asghar S; Wu Y; Kambere Amerigos D; Chen Z; Zhang M; Yin L; Huang L; Ping Q; Xiao Y Drug Deliv; 2017 Nov; 24(1):1605-1616. PubMed ID: 29063815 [TBL] [Abstract][Full Text] [Related]
8. Thermosensitive in situ nanogel as ophthalmic delivery system of curcumin: development, characterization, in vitro permeation and in vivo pharmacokinetic studies. Liu R; Sun L; Fang S; Wang S; Chen J; Xiao X; Liu C Pharm Dev Technol; 2016 Aug; 21(5):576-82. PubMed ID: 26024239 [TBL] [Abstract][Full Text] [Related]
9. In vivo Antiplasmodial Activity of Curcumin-Loaded Nanostructured Lipid Carriers. Rashidzadeh H; Salimi M; Sadighian S; Rostamizadeh K; Ramazani A Curr Drug Deliv; 2019; 16(10):923-930. PubMed ID: 31663477 [TBL] [Abstract][Full Text] [Related]
10. Chitosan oligosaccharide enhances binding of nanostructured lipid carriers to ocular mucins: Effect on ocular disposition. Pai RV; Vavia PR Int J Pharm; 2020 Mar; 577():119095. PubMed ID: 32004680 [TBL] [Abstract][Full Text] [Related]
11. Topical ophthalmic lipid nanoparticle formulations (SLN, NLC) of indomethacin for delivery to the posterior segment ocular tissues. Balguri SP; Adelli GR; Majumdar S Eur J Pharm Biopharm; 2016 Dec; 109():224-235. PubMed ID: 27793755 [TBL] [Abstract][Full Text] [Related]
12. The potential use of novel chitosan-coated deformable liposomes in an ocular drug delivery system. Chen H; Pan H; Li P; Wang H; Wang X; Pan W; Yuan Y Colloids Surf B Biointerfaces; 2016 Jul; 143():455-462. PubMed ID: 27037783 [TBL] [Abstract][Full Text] [Related]
13. Nanostructured lipid carriers enhance the bioavailability and brain cancer inhibitory efficacy of curcumin both in vitro and in vivo. Chen Y; Pan L; Jiang M; Li D; Jin L Drug Deliv; 2016 May; 23(4):1383-92. PubMed ID: 26066035 [TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetic studies and anticancer activity of curcumin-loaded nanostructured lipid carriers. Wang F; Chen J; Dai W; He Z; Zhai D; Chen W Acta Pharm; 2017 Sep; 67(3):357-371. PubMed ID: 28858837 [TBL] [Abstract][Full Text] [Related]
15. Ocular amphotericin B delivery by chitosan-modified nanostructured lipid carriers for fungal keratitis-targeted therapy. Fu T; Yi J; Lv S; Zhang B J Liposome Res; 2017 Sep; 27(3):228-233. PubMed ID: 27601177 [TBL] [Abstract][Full Text] [Related]
16. Inducing sustained release and improving oral bioavailability of curcumin via chitosan derivatives-coated liposomes. Tian MP; Song RX; Wang T; Sun MJ; Liu Y; Chen XG Int J Biol Macromol; 2018 Dec; 120(Pt A):702-710. PubMed ID: 30170061 [TBL] [Abstract][Full Text] [Related]
17. Nanostructured lipid carriers as novel ophthalmic delivery system for mangiferin: improving in vivo ocular bioavailability. Liu R; Liu Z; Zhang C; Zhang B J Pharm Sci; 2012 Oct; 101(10):3833-44. PubMed ID: 22767401 [TBL] [Abstract][Full Text] [Related]
18. Co-delivery of etoposide and curcumin by lipid nanoparticulate drug delivery system for the treatment of gastric tumors. Jiang H; Geng D; Liu H; Li Z; Cao J Drug Deliv; 2016 Nov; 23(9):3665-3673. PubMed ID: 27749102 [TBL] [Abstract][Full Text] [Related]
19. Du Z; Liu J; Zhang H; Wu X; Zhang B; Chen Y; Liu B; Ding L; Xiao H; Zhang T J Agric Food Chem; 2019 Nov; 67(45):12511-12519. PubMed ID: 31626537 [TBL] [Abstract][Full Text] [Related]
20. Nanostructured lipid carrier surface modified with Eudragit RS 100 and its potential ophthalmic functions. Zhang W; Li X; Ye T; Chen F; Yu S; Chen J; Yang X; Yang N; Zhang J; Liu J; Pan W; Kong J Int J Nanomedicine; 2014; 9():4305-15. PubMed ID: 25246787 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]